Atomic AI

📍 South San Francisco, United States👥 32 employees💰 Last funded Aug 2024
Biotechnology Research🌐 atomic.ai
Website LinkedIn
Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research featured on the cover of Science (doi.org/10.1126/science.abe5650), provides new strategies to treat or cure previously-undruggable diseases by targeting RNA structure. We are an interdisciplinary team working across computational and experimental biology and believe that our strongest asset is our people. Were hiring! https://boards.greenhouse.io/atomai
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2022–2024 · investors recorded per year
202222023120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Atomic AI?
Atomic AI has 4 investors on record on gritt.io.
When did Atomic AI last raise funding?
The most recent investment in Atomic AI recorded on gritt.io was in August 2024.
What industry is Atomic AI in?
Atomic AI operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Atomic AI based?
Atomic AI is headquartered in South San Francisco, United States.